Subjects: Humans and Treatment Outcome - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Humans ✖ Subjects Treatment Outcome ✖ Publication Year 2017 to 2019 ✖

1. Are you ready to respond?: reports of high harm complications after surgery and invasive procedures

Author(s):: Magee, Mary C., author
Finley, Edward, author
Liberatore, Kim, author
Publication:: [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, December 2018
Subject(s):: Clinical Deterioration
Failure to Rescue, Health Care -- statistics & numerical data
Intraoperative Complications -- mortality
Intraoperative Complications -- prevention & control
Postoperative Complications -- mortality
Postoperative Complications -- prevention & control
Surgical Procedures, Operative -- adverse effect
Surgical Procedures, Operative -- mortality
Anatomy
Blood Loss, Surgical
Blood Transfusion
Hospital Rapid Response Team
Medical Errors -- prevention & control
Patient Safety
Resuscitation -- methods
Treatment Outcome
Humans
Pennsylvania
United States

2. Dupilumab and crisaborole for atopic dermatitis: effectiveness and value : final evidence report and meeting summary

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 8, 2017
Subject(s):: Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic -- drug therapy
Interleukin-4 Receptor alpha Subunit -- antagonists & inhibitors
Phosphodiesterase 4 Inhibitors -- therapeutic use
Antibodies, Monoclonal -- adverse effects
Cost-Benefit Analysis
Cyclosporine -- therapeutic use
Phosphodiesterase 4 Inhibitors -- adverse effects
Phototherapy
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States

3. Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer: effectiveness and value : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
Subject(s):: Ovarian Neoplasms -- drug therapy
Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
Comparative Effectiveness Research
Poly(ADP-ribose) Polymerase Inhibitors -- adverse effects
Poly(ADP-ribose) Polymerase Inhibitors -- economics
Treatment Outcome
Humans
United States

4. Cognitive and mind-body therapies for chronic low back and neck pain: effectiveness and value : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, November 6, 2017
Subject(s):: Chronic Pain -- therapy
Cognitive Therapy
Low Back Pain -- therapy
Mind-Body Therapies
Neck Pain -- therapy
Acupuncture Therapy -- economics
Comparative Effectiveness Research
Mindfulness -- economics
Tai Ji -- economics
Treatment Outcome
Yoga
Humans
United States

5. Disease-modifying therapies for relapsing-remitting and primary-progressive multiple sclerosis: effectiveness and value : final evidence report

Publication:: Boston, MA : Institute for Clinical and Economic Review, March 6, 2017
Subject(s):: Comparative Effectiveness Research
Multiple Sclerosis, Chronic Progressive -- drug therapy
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- economics
Antirheumatic Agents -- therapeutic use
Benchmarking
Cost-Benefit Analysis
Immunosuppressive Agents -- adverse effects
Immunosuppressive Agents -- economics
Immunosuppressive Agents -- therapeutic use
Insurance Coverage
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States

6. Targeted immune modulators for rheumatoid arthritis: effectiveness & value : evidence report

7. Voretigene neparvovec for biallelic RPE65-mediated retinal disease: effectiveness and value : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, February 14, 2018
Subject(s):: Genetic Therapy
Leber Congenital Amaurosis -- genetics
Leber Congenital Amaurosis -- therapy
Retinal Diseases -- genetics
Retinal Diseases -- therapy
Retinal Pigment Epithelium -- abnormalities
Mutation
Randomized Controlled Trials as Topic
Treatment Outcome
Visual Acuity
Humans
United States

8. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018
Subject(s):: Immunotherapy, Adoptive
Leukemia, B-Cell -- drug therapy
Lymphoma, B-Cell -- drug therapy
Lymphoma, Non-Hodgkin -- drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
Adult
Child
Clinical Trials as Topic
Clofarabine -- therapeutic use
Cost-Benefit Analysis
Immunotherapy, Adoptive -- adverse effects
Immunotherapy, Adoptive -- economics
Receptors, Chimeric Antigen -- therapeutic use
Treatment Outcome
Humans
United States

9. Emicizumab for hemophilia A with inhibitors: effectiveness and value : final evidence report

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 16, 2018
Subject(s):: Antibodies, Bispecific -- therapeutic use
Antibodies, Monoclonal -- therapeutic use
Hemophilia A -- drug therapy
Antibodies, Bispecific -- adverse effects
Antibodies, Monoclonal -- adverse effects
Cost-Benefit Analysis
Treatment Outcome
Humans
United States

10. Modulator treatments for cystic fibrosis: effectiveness and value : final evidence report and meeting summary

Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 7, 2018
Subject(s):: Cystic Fibrosis -- drug therapy
Cystic Fibrosis Transmembrane Conductance Regulator -- therapeutic use
Clinical Trials as Topic
Cost of Illness
Cost-Benefit Analysis
Cystic Fibrosis Transmembrane Conductance Regulator -- adverse effects
Treatment Outcome
Humans
United States